Two drugs, eszopiclone and lemborexant – both not currently licenced for the treatment of insomnia in the UK – were shown to perform better than others, both in the acute…
On 21st of June 2022, around 30 Oxford researchers and 12 public contributors came together at Oxford’s Old Fire Station to discuss ways of involving people from diverse communities in…
